Jamjoom Bakur A, Jamjoom Abdulhakim B
Department of Surgery, Section of Neurosurgery, King Khalid National Guards Hospital, P O Box 9515, Jeddah 21423, Saudi Arabia.
BMC Musculoskelet Disord. 2014 May 5;15:146. doi: 10.1186/1471-2474-15-146.
This study is a descriptive review of the literature aimed at examining the efficacy of the use of intraoperative epidural steroids in lumbar disc surgery, a matter that remains controversial.
The relevant clinical trials were selected from databases and reviewed. The methodological quality of each included study was assessed and graded for perceived risk of bias. All the documented significant and non-significant findings were collected. Our outcome targets were reduction in postoperative pain scores, consumption of analgesia, duration of hospital stay and no increase in complication rates. The variation in the timing of postoperative pain assessments necessitated grouping the outcome into three postoperative stages; early: 0 to 2 weeks, intermediate: more than 2 weeks to 2 months and late: more than 2 months to 1 year.
Sixteen trials that were published from 1990 to 2012 were eligible. At least one significant reduction in pain score was reported in nine of the eleven trials that examined pain in the early stage, in four of the seven trials that examined pain in the intermediate stage and in two of the eight trials that examined pain in the late stage. Seven of the nine trials that looked at consumption of postoperative analgesia reported significant reduction while six of the ten trails that examined the duration of hospital stay reported significant reduction. None of the trials reported a significant increase of steroid-related complications.
There is relatively strong evidence that intraoperative epidural steroids are effective in reducing pain in the early stage and reducing consumption of analgesia. There is also relatively strong evidence that they are ineffective in reducing pain in the late stage and in reducing duration of hospital stay. The evidence for their effectiveness in reducing pain in the intermediate stage is considered relatively weak. The heterogeneity between the trials makes it difficult to make undisputed conclusions and it indicates the need for a large multicenter trial with validated outcome measures that are recorded at fixed time intervals.
本研究是一项文献描述性综述,旨在探讨腰椎间盘手术中使用术中硬膜外类固醇的疗效,这一问题仍存在争议。
从数据库中筛选相关临床试验并进行综述。对每项纳入研究的方法学质量进行评估,并根据感知到的偏倚风险进行分级。收集所有记录的显著和非显著结果。我们的结果指标包括术后疼痛评分降低、镇痛药物用量、住院时间以及并发症发生率无增加。术后疼痛评估时间的差异使得有必要将结果分为术后三个阶段;早期:0至2周,中期:超过2周至2个月,晚期:超过2个月至1年。
1990年至2012年发表的16项试验符合要求。在11项早期疼痛研究中,有9项报告疼痛评分至少有一次显著降低;在7项中期疼痛研究中,有4项报告疼痛评分显著降低;在8项晚期疼痛研究中,有2项报告疼痛评分显著降低。在9项术后镇痛药物用量研究中,有7项报告显著降低;在10项住院时间研究中,有6项报告显著降低。没有试验报告类固醇相关并发症显著增加。
有相对充分的证据表明术中硬膜外类固醇在早期可有效减轻疼痛并减少镇痛药物用量。也有相对充分的证据表明其在晚期减轻疼痛和缩短住院时间方面无效。其在中期减轻疼痛的有效性证据相对较弱。试验之间的异质性使得难以得出无可争议的结论,这表明需要进行一项大型多中心试验,采用在固定时间间隔记录的经过验证的结果指标。